Migdal Insurance & Financial Holdings Ltd. Pfizer Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.18 Billion
  • Q3 2024

A detailed history of Migdal Insurance & Financial Holdings Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Migdal Insurance & Financial Holdings Ltd. holds 4,067 shares of PFE stock, worth $107,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,067
Previous 3,605 12.82%
Holding current value
$107,450
Previous $100,000 18.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$27.7 - $31.39 $12,797 - $14,502
462 Added 12.82%
4,067 $118,000
Q2 2024

Jul 29, 2024
BUY
$25.26 - $29.6 $91,062 - $106,708
3,605 New
3,605 $100,000
Q4 2023

Jan 31, 2024
SELL
$26.13 - $33.94 $46 Million - $59.8 Million
-1,761,741 Reduced 98.18%
32,748 $943,000
Q3 2023

Oct 25, 2023
BUY
$32.09 - $37.51 $161,797 - $189,125
5,042 Added 0.28%
1,794,489 $59.5 Million
Q2 2023

Jul 24, 2023
BUY
$36.12 - $41.79 $33.7 Million - $39 Million
932,540 Added 108.83%
1,789,447 $65.6 Million
Q1 2023

May 01, 2023
BUY
$39.39 - $51.28 $33.5 Million - $43.6 Million
850,566 Added 13413.75%
856,907 $35 Million
Q4 2022

Jan 23, 2023
BUY
$41.75 - $54.5 $53,899 - $70,359
1,291 Added 25.56%
6,341 $324,000
Q3 2022

Oct 31, 2022
SELL
$43.76 - $53.42 $301,944 - $368,598
-6,900 Reduced 57.74%
5,050 $224,000
Q2 2022

Aug 10, 2022
SELL
$46.53 - $55.17 $88.9 Million - $105 Million
-1,911,000 Reduced 99.38%
11,950 $622,000
Q1 2022

May 02, 2022
BUY
$45.75 - $56.69 $372,862 - $462,023
8,150 Added 0.43%
1,922,950 $99.6 Million
Q4 2021

Feb 02, 2022
SELL
$41.32 - $61.25 $917,097 - $1.36 Million
-22,195 Reduced 1.15%
1,914,800 $113 Million
Q3 2021

Nov 16, 2021
BUY
$39.25 - $50.42 $8.78 Million - $11.3 Million
223,602 Added 13.05%
1,936,995 $83.3 Million
Q2 2021

Aug 04, 2021
BUY
$35.91 - $40.68 $60.8 Million - $68.8 Million
1,691,842 Added 7850.41%
1,713,393 $67.1 Million
Q1 2021

May 04, 2021
BUY
$33.49 - $37.77 $666,517 - $751,698
19,902 Added 1206.91%
21,551 $781,000
Q4 2020

Feb 08, 2021
SELL
$33.47 - $42.56 $5,087 - $6,469
-152 Reduced 8.44%
1,649 $61,000
Q3 2020

Nov 05, 2020
SELL
$31.75 - $37.25 $20,478 - $24,026
-645 Reduced 26.37%
1,801 $66,000
Q2 2020

Aug 11, 2020
SELL
$30.12 - $36.54 $451 - $548
-15 Reduced 0.61%
2,446 $80,000
Q1 2020

May 12, 2020
BUY
$27.03 - $38.62 $66,520 - $95,043
2,461 New
2,461 $80,000
Q3 2019

Nov 12, 2019
SELL
$32.49 - $42.13 $20.9 Million - $27 Million
-641,947 Closed
0 $0
Q2 2019

Aug 08, 2019
SELL
$36.98 - $41.52 $6.82 Million - $7.66 Million
-184,522 Reduced 22.33%
641,947 $27.8 Million
Q1 2019

May 01, 2019
BUY
$37.5 - $41.2 $14.5 Million - $15.9 Million
386,671 Added 87.92%
826,469 $35.1 Million
Q4 2018

Feb 13, 2019
SELL
$38.47 - $43.86 $10.5 Million - $12 Million
-274,106 Reduced 38.4%
439,798 $19.2 Million
Q3 2018

Nov 08, 2018
BUY
$34.47 - $41.81 $849,375 - $1.03 Million
24,641 Added 3.57%
713,904 $31.5 Million
Q2 2018

Aug 01, 2018
BUY
$32.98 - $35.16 $531,043 - $566,146
16,102 Added 2.39%
689,263 $25 Million
Q1 2018

May 02, 2018
BUY
$31.91 - $37.02 $26,485 - $30,726
830 Added 0.12%
673,161 $23.9 Million
Q4 2017

Feb 06, 2018
BUY
$33.26 - $35.29 $74,302 - $78,837
2,234 Added 0.33%
672,331 $24.4 Million
Q3 2017

Nov 06, 2017
BUY
$31.0 - $34.15 $140,740 - $155,041
4,540 Added 0.68%
670,097 $23.9 Million
Q2 2017

Aug 15, 2017
BUY
N/A
665,557
665,557 $22.4 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email